sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
term
sarscov
antivir
treatment
establish
far
interferon
cytokin
induc
synthesi
sever
antivir
activ
protein
cell
studi
demonstr
multipl
sarscov
cell
cultur
strongli
inhibit
pretreat
interferonbeta
interferonalpha
interferongamma
contrast
less
effect
human
mxa
protein
one
promin
protein
induc
interferonbeta
nevertheless
interfer
sarscov
replic
observ
vero
cell
stabli
express
mxa
therefor
interferoninduc
protein
must
respons
strong
inhibitori
effect
interferonbeta
sarscov
sever
acut
respiratori
syndrom
sar
infecti
diseas
recent
emerg
china
rapidli
spread
countri
date
case
death
report
intens
research
led
identif
positivestrand
rna
viru
term
sarscoronaviru
sarscov
etiolog
agent
fouchier
et
al
ksiazek
et
al
kuiken
et
al
peiri
et
al
viru
infect
mammalian
cell
prompt
innat
immun
system
establish
first
line
defens
interferon
ifn
play
key
role
event
sinc
activ
innat
immun
system
help
shape
adapt
immun
stark
et
al
establish
antivir
state
type
ifn
synthes
cell
type
direct
respons
viru
infect
wherea
type
ii
ifn
produc
immun
cell
contact
antigenpres
cell
type
type
ii
ifn
induc
synthesi
distinct
partial
overlap
set
mrna
encod
protein
antivir
antiprolif
immunomodulatori
properti
de
veer
et
al
among
type
ifninduc
protein
main
antivir
factor
mx
protein
haller
koch
oligoadenyl
synthetas
oa
rnasel
system
silverman
protein
kinas
r
pkr
william
mx
protein
larg
gtpase
inhibit
multipl
sever
rna
virus
includ
repres
member
bunyavirida
paramyxovirida
rhabdovirida
orthomyxovirida
togavirida
haller
koch
mx
protein
inhibit
viru
replic
earli
stage
infect
affect
transcript
andor
replic
viral
genom
haller
koch
studi
investig
potenti
differ
ifn
inhibit
replic
sarscov
cell
cultur
determin
whether
human
mxa
protein
contribut
antivir
effect
type
ifn
african
green
monkey
kidney
vero
cell
grown
dulbecco
modifi
eagl
medium
contain
fetal
calf
serum
vero
cell
clone
perman
transfect
mxa
express
plasmid
frese
et
al
grown
medium
plu
mg
per
ml
isol
sarscov
kindli
provid
stephan
becker
univers
marburg
germani
human
ad
bglii
pegyl
purchas
pbl
biomed
laboratori
griffith
micro
scienc
schere
sigma
respect
viru
plaqu
assay
perform
describ
previous
frese
et
al
briefli
vero
cell
monolay
infect
dilut
supernat
infect
cell
overlaid
soft
agar
allow
form
plaqu
h
agar
overlay
remov
cell
stain
solut
crystal
violet
formaldehyd
methanol
ethanol
investig
inhibitori
effect
type
ii
ifn
sarscov
multipl
cell
cultur
use
univers
ad
bglii
pegyl
human
human
human
cytokin
known
inhibit
replic
sever
pathogen
virus
cell
cultur
patient
samuel
follow
experi
vero
cell
chosen
unabl
synthes
ifn
fulli
respons
ifn
treatment
diaz
et
al
therefor
addit
effect
virusinduc
ifn
would
bia
result
exclud
cell
pretreat
ifn
infect
sarscov
viru
supernat
determin
overnight
incub
fig
show
administr
led
inhibit
viru
growth
even
potent
sinc
result
reduct
viru
titer
also
test
tumor
necrosi
factor
found
inhibitori
effect
data
shown
data
agreement
recent
report
cinatl
et
al
demonstr
effect
antivir
cytokin
sarscov
mx
one
main
protein
antivir
activ
previou
gene
array
analys
reveal
mrna
human
mxa
protein
induc
der
et
al
due
similar
antivir
effect
differ
ifn
see
fig
pattern
mxa
express
suspect
mxa
might
respons
factor
therefor
test
growth
sarscov
vero
cell
line
stabli
express
mxa
frese
et
al
cell
wide
use
demonstr
antivir
effect
mxa
rang
rna
virus
haller
koch
vero
cell
express
mxa
control
cell
vero
infect
sarscov
isol
viral
titer
supernat
determin
h
postinfect
depict
fig
appar
differ
viru
growth
detect
case
titer
approxim
infecti
particl
per
ml
reach
likewis
mxaexpress
control
vero
cell
directli
use
plaqu
assay
differ
effici
plaqu
format
size
observ
fig
result
suggest
mxa
critic
factor
mediat
inhibit
sarscov
despit
highlevel
induct
thu
search
antivir
effect
sarscov
focu
ifninduc
protein
pkr
rnase
l
